Sapiens (SPNS) Misses Q3 EPS by 6c

Sapiens (NASDAQ: SPNS) reported Q3 EPS of $0.24, $0.06 worse than the analyst estimate of $0.30. Revenue for the quarter came in at $119 million versus the consensus estimate of $122.83 million.

For earnings history and earnings-related data on Sapiens (SPNS) click here.

You May Also Be Interested In

• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
• Aebi Schmidt Holding AG (AEBI) Reports Q2 results; offers guidance
• Cellectar Biosciences (CLRB) Misses Q2 EPS by 9c